# Pfizer Inc. (PFE) — Q2-2019 Earnings Results

**Report date:** 2019-07-29 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q2-2019

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Down 3.81%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.80 | N/A | +1.42% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about future projects. They emphasized the importance of innovation while recognizing competitive pressures.

**Key quotes:**

> Management highlighted ongoing efforts in research and development.

> They expressed confidence in their pipeline but acknowledged market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's earnings report showed a slight beat on EPS, which indicates some positive performance. However, the stock fell by 3.81%, likely due to the lack of revenue details and forward guidance. Investors may be concerned about the company's future prospects given the competitive landscape and absence of specific targets.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q2-2019_